Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 16 (12), 3113-20

Cancer Stem Cells and Self-Renewal


Cancer Stem Cells and Self-Renewal

Catherine Adell O'Brien et al. Clin Cancer Res.


The cancer stem cell (CSC) or cancer-initiating cancer (C-IC) model has garnered considerable attention over the past several years since Dick and colleagues published a seminal report showing that a hierarchy exists among leukemic cells. In more recent years, a similar hierarchical organization, at the apex of which exists the CSC, has been identified in a variety of solid tumors. Human CSCs are defined by their ability to: (i) generate a xenograft that histologically resembles the parent tumor from which it was derived, (ii) be serially transplanted in a xenograft assay thereby showing the ability to self-renew (regenerate), and (iii) generate daughter cells that possess some proliferative capacity but are unable to initiate or maintain the cancer because they lack intrinsic regenerative potential. The emerging complexity of the CSC phenotype and function is at times daunting and has led to some confusion in the field. However, at its core, the CSC model is about identifying and characterizing the cancer cells that possess the greatest capacity to regenerate all aspects of the tumor. It is becoming clear that cancer cells evolve as a result of their ability to hijack normal self-renewal pathways, a process that can drive malignant transformation. Studying self-renewal in the context of cancer and CSC maintenance will lead to a better understanding of the mechanisms driving tumor growth. This review will address some of the main controversies in the CSC field and emphasize the importance of focusing first and foremost on the defining feature of CSCs: dysregulated self-renewal capacity.

Similar articles

  • Cancer Stem Cells in Solid Tumors
    LE Ailles et al. Curr Opin Biotechnol 18 (5), 460-6. PMID 18023337. - Review
    Cancer stem cells (CSCs) are cells that drive tumorigenesis, as well as giving rise to a large population of differentiated progeny that make up the bulk of the tumor, bu …
  • Recurrence Cancer Stem Cells--Made by Cell Fusion?
    T Dittmar et al. Med Hypotheses 73 (4), 542-7. PMID 19564079.
    Within the past 10-15 years our knowledge about cancer and how cancer cells might originate has changed dramatically. It is now generally believed that a tumor has its or …
  • Evidence for Cancer Stem Cells in Human Endometrial Carcinoma
    SA Hubbard et al. Cancer Res 69 (21), 8241-8. PMID 19843861.
    Emerging evidence indicates that the highly regenerative human endometrium harbors rare populations of epithelial progenitor cells. In tumors of other regenerative epithe …
  • Die Hard: Are Cancer Stem Cells the Bruce Willises of Tumor Biology?
    A Fábián et al. Cytometry A 75 (1), 67-74. PMID 19051297. - Review
    In recent years, an exponentially growing number of studies have focused on identifying cancer stem cells (CSC) in human malignancies. The rare CSCs could be crucial in c …
  • Cancer Stem Cells in Hepatocellular Carcinoma: Recent Progress and Perspective
    T Chiba et al. Cancer Lett 286 (2), 145-53. PMID 19464789. - Review
    Although the "cancer stem cell (CSC)" hypothesis was first proposed roughly 50 years ago, recent progress in stem cell biology and technologies has successfully achieved …
See all similar articles

Cited by 154 PubMed Central articles

See all "Cited by" articles

LinkOut - more resources